Gail Frances McIntyre Insider Trading
Get free email notifications about insider trading for Gail Frances McIntyre.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Gail Frances McIntyre. Gail Frances McIntyre is a Senior Vice President-Research in Furiex Pharmaceuticals, Inc. ($FURX) and a CEO and President in Aravive, Inc. ($ARAV) and a Chief Scientific Officer in Aravive, Inc. ($ARAV).
Address: C/O FURIEX PHARMACEUTICALS, INC. 3900 PARAMOUNT PARKWAY, SUITE 150 MORRISVILLE 27560 NC
Companies in which Gail Frances McIntyre is an Insider
Aravive, Inc.
Trading Symbol: ARAVIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gail Frances McIntyre: CEO and President, Chief Scientific Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 26 2021
$ARAV Market Capitalization: $474.95M
$ARAV Previous Close: $13.30
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Furiex Pharmaceuticals, Inc.
Trading Symbol: FURXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Gail Frances McIntyre: Senior Vice President-Research
Holdings: 6,768 shares
Latest Transaction: Apr 11 2012
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Gail Frances McIntyre
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 26 2021 | ARAV | Aravive, Inc. | McIntyre Gail Frances | CEO and President | Option Exercise | A | 5.95 | 165,000 | 981,750 | 165,000 | |
Apr 09 2020 | ARAV | Aravive, Inc. | McIntyre Gail Frances | CEO and President | Option Exercise | A | 6.16 | 80,000 | 492,800 | 80,000 | |
Apr 09 2020 | ARAV | Aravive, Inc. | McIntyre Gail Frances | CEO and President | Option Exercise | A | 6.16 | 80,000 | 492,800 | 80,000 | |
Jan 24 2020 | ARAV | Aravive, Inc. | McIntyre Gail Frances | Chief Scientific Of ... | Option Exercise | A | 10.84 | 48,583 | 526,640 | 48,583 | |
Apr 11 2012 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Option Exercise | A | 17.80 | 10,368 | 184,550 | 10,368 | |
Nov 21 2011 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Buy | P | 16.89 | 6,500 | 109,785 | 6,768 | 268 to 6.8 K (+2,425.37 %) |
Oct 05 2011 | FURX | Furiex Pharmaceuti ... | McIntyre Gail Frances | Senior Vice Preside ... | Option Exercise | A | 13.16 | 37,944 | 499,343 | 37,944 |